Does Triumeq cause weight gain?
Weight gain is an uncommon side effect of Triumeq that has been reported in post-marketing reports – these are studies done after a drug has been approved. Weight gain was not noted as a side effect of Triumeq in clinical trials and is not documented as a side effect in the product information. The incidence of weight gain with Triumeq is not known, but recent studies have reported that one in six people starting HIV treatment gain at least 10% in body weight over one to two years. The risk is higher in people who start treatment with a combination that contains the integrase inhibitors dolutegravir, bictegravir, or elvitegravir, or the NRTI tenofovir alafenamide (TAF). Trimueq contains dolutegravir.
Weight gain is more common in women, black people, and in those with a low CD4 count or who were in poorer health before starting treatment. It is unclear why some people gain weight with Triumeq but it may be due to:
If you have unexpected weight gain while taking Triumeq then talk to your doctor about it. Weight gain associated with HIV treatment may increase the risk of diabetes, cardiovascular disease, and several other conditions.
Triumeq is a fixed-dose combination tablet that contains three antivirals: abacavir, dolutegravir, and lamivudine, which may be used to treat human immunodeficiency virus type 1 (HIV-1) infection in adults and children weighing at least 40 kg (88 pounds).
Related medical questions
- Can Triumeq be used for PrEP?
- Does Triumeq cause erectile dysfunction?
- Does Triumeq cause weight gain?
- Does Triumeq cause hair loss?
- Triumeq vs Genvoya. How do they compare?
- How long does it take to work?
- Can Triumeq be crushed or split?
- Is Triumeq an immunosuppressant?
- Can Triumeq be used for PrEP?
- Does Triumeq cause erectile dysfunction?
- Does Triumeq cause weight gain?
- Triumeq vs Genvoya. How do they compare?
- Does Triumeq cause hair loss?
- How long does it take to work?
- Can Triumeq be crushed or split?
- Is Triumeq an immunosuppressant?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions